Emerging innovations and advancements in the treatment of extremity and truncal soft tissue sarcomas

Walker, Kyle; Simister, Samuel K.; Carr‐Ascher, Janai; Monument, Michael J.; Thorpe, Steven W.; Randall, R. Lor

doi:10.1002/jso.27526

Cited by 3 publications

(1 citation statement)

References 175 publications

(289 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Musculoskeletal (MSK) oncology is a distinct specialty encompassing the complexities of primary and metastatic bone cancer, soft tissue sarcoma, and benign bone tumors, compounded by the potential for significant treatment and disease-associated morbidity. In recent years, MSK oncology has dramatically evolved, focusing on enhancing patient care through advancements in multimodal management strategies, surgical techniques, medical and pharmacological treatments, patient-reported outcomes, and surveillance protocols [ 1 , 2 ]. While continuing to evolve, the pathologies in MSK oncology pose many challenges in developing clinical evidence for informed decision-making due to the complex manifestations and heterogeneous disease sequelae and their rarity [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

The Benefit of an Umbrella Protocol: Reducing Challenges in Orthopedic Oncology Research

Simister,

Tse,

Saade

et al. 2024

JCM

Self Cite

View full text Add to dashboard Cite

Background: Orthopedic oncology research is hindered by the scarcity of musculoskeletal tumors and research administrative inefficiencies. This paper introduces observational research through an innovative institution-specific methodology—termed an umbrella protocol. This protocol outlines a comprehensive standard procedure to expedite ethical approval for future aligned studies, reducing administrative barriers to research. Methods: We developed an umbrella protocol at an academic center, involving meticulous methodological identification and coordination with the institutional review board (IRB) to adhere to local guidelines. The protocol encompasses identifying investigators, research objectives, study goals, and data and safety monitoring frameworks necessary for typical standards. Results: Implementation of the umbrella protocol took 110 days to achieve exemption status, following multiple discussions with the IRB and extensive revisions. At the authors institution, this protocol significantly reduces protocol review times from an average of six-to-eight weeks to nearly instantaneous, facilitating a streamlined research process. Additionally, we established a dedicated orthopedic oncology patient registry to enhance future research endeavors. Conclusions: The adoption of umbrella protocols represents a pioneering strategy in orthopedic oncology. This approach mitigates research administrative burdens and broadens research scope in the field. It underscores the necessity of IRB collaboration, methodological precision, and stringent data management. The article also reflects on the ethical implications and potential biases introduced by emerging technologies like artificial intelligence, advocating for diligent ethical oversight. The establishment of an umbrella protocol marks a significant step towards more efficient research methodologies, ultimately aiming to improve patient care and outcomes for individuals with rare musculoskeletal conditions.

show abstract

Section: Introductionmentioning

confidence: 99%